Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Federal Drug Pricing Policies Irk Biotech Insiders No Photo Available

Yeji Jesse Lee

As the federal government rolls out a series of policies aimed at lowering drug prices and reducing healthcare costs, biotech insiders... (more story)

Blip Or Trend? FDA Guidance Fell Off Steeply In 2025 No Photo Available

Dan McKay

The U.S. Food and Drug Administration issued far less industry guidance last year after President Donald Trump returned to office. The... (more story)

The Curious, Very Long Delay In A Pioneering Drug Prices Suit No Photo Available

Jeff Overley

When Merck & Co. launched a fiery challenge to Medicare's landmark drug price negotiations, it blazed a trail for many similar suits. ... (more story)